NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 262 filers reported holding NEKTAR THERAPEUTICS in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $51,315 | -68.9% | 73,004 | 0.0% | 0.00% | – |
| Q4 2022 | $164,989 | -29.0% | 73,004 | +0.6% | 0.00% | – |
| Q3 2022 | $232,317 | -18.5% | 72,599 | -3.3% | 0.00% | – |
| Q2 2022 | $285,205 | -92.5% | 75,054 | -64.5% | 0.00% | -100.0% |
| Q3 2021 | $3,801,000 | +11.0% | 211,621 | +6.0% | 0.00% | 0.0% |
| Q2 2021 | $3,425,000 | -16.2% | 199,614 | -2.3% | 0.00% | -25.0% |
| Q1 2021 | $4,088,000 | +11.2% | 204,383 | -5.5% | 0.00% | +33.3% |
| Q4 2020 | $3,676,000 | -5.5% | 216,226 | -7.8% | 0.00% | -25.0% |
| Q3 2020 | $3,890,000 | -27.3% | 234,485 | -1.7% | 0.00% | -20.0% |
| Q2 2020 | $5,350,000 | +18.9% | 238,604 | -5.3% | 0.01% | 0.0% |
| Q1 2020 | $4,498,000 | -15.6% | 252,004 | +2.1% | 0.01% | -16.7% |
| Q4 2019 | $5,329,000 | +75.6% | 246,896 | +45.6% | 0.01% | +100.0% |
| Q3 2019 | $3,035,000 | -46.9% | 169,514 | +5.6% | 0.00% | -57.1% |
| Q2 2019 | $5,712,000 | -1.4% | 160,511 | -6.9% | 0.01% | +16.7% |
| Q1 2019 | $5,792,000 | +2.4% | 172,373 | +0.1% | 0.01% | -14.3% |
| Q4 2018 | $5,659,000 | -47.4% | 172,201 | -2.3% | 0.01% | -36.4% |
| Q3 2018 | $10,749,000 | +26.6% | 176,335 | +1.4% | 0.01% | +22.2% |
| Q2 2018 | $8,490,000 | -70.2% | 173,835 | -35.2% | 0.01% | -71.9% |
| Q1 2018 | $28,499,000 | +324.3% | 268,201 | +138.5% | 0.03% | +357.1% |
| Q4 2017 | $6,716,000 | +148.6% | 112,452 | -0.1% | 0.01% | +133.3% |
| Q3 2017 | $2,702,000 | +20.9% | 112,583 | -1.6% | 0.00% | 0.0% |
| Q2 2017 | $2,235,000 | -14.0% | 114,357 | +3.3% | 0.00% | 0.0% |
| Q1 2017 | $2,598,000 | +13.8% | 110,674 | -40.5% | 0.00% | 0.0% |
| Q4 2016 | $2,283,000 | -15.8% | 186,041 | +17.9% | 0.00% | -25.0% |
| Q3 2016 | $2,712,000 | +20.4% | 157,856 | -0.2% | 0.00% | +33.3% |
| Q2 2016 | $2,252,000 | -2.9% | 158,245 | -7.4% | 0.00% | +50.0% |
| Q1 2016 | $2,320,000 | +59.6% | 170,971 | +98.0% | 0.00% | +100.0% |
| Q4 2015 | $1,454,000 | -30.2% | 86,329 | -54.6% | 0.00% | -50.0% |
| Q3 2015 | $2,082,000 | +100.4% | 189,953 | +128.8% | 0.00% | +100.0% |
| Q2 2015 | $1,039,000 | +12.6% | 83,036 | -1.1% | 0.00% | 0.0% |
| Q1 2015 | $923,000 | -26.2% | 83,929 | +4.0% | 0.00% | -50.0% |
| Q4 2014 | $1,251,000 | +25.6% | 80,672 | -2.3% | 0.00% | +100.0% |
| Q3 2014 | $996,000 | -3.4% | 82,553 | +2.6% | 0.00% | -50.0% |
| Q2 2014 | $1,031,000 | -9.1% | 80,465 | -14.1% | 0.00% | 0.0% |
| Q1 2014 | $1,134,000 | +13.4% | 93,628 | +6.3% | 0.00% | 0.0% |
| Q4 2013 | $1,000,000 | +9.3% | 88,059 | +0.6% | 0.00% | 0.0% |
| Q3 2013 | $915,000 | -11.9% | 87,558 | -2.7% | 0.00% | 0.0% |
| Q2 2013 | $1,039,000 | – | 89,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |